Sensitive analytical method for the novel H1-receptor antagonist HSR-609 in human plasma and urine by high-performance liquid chromatography with pre-column fluorescent derivatization.
H Hasegawa, E Takahara, T Yamada, O Nagata
Index: J. Chromatogr. B, Biomed. Appl. 687(2) , 419-25, (1996)
Full Text: HTML
Abstract
A simple and sensitive method for quantitation of HSR-609 (I) in human plasma and urine was developed using HPLC with the fluorescence labelling reagent 4-(N,N-dimethylaminosulfonyl)-7-N-piperazino-2,1,3-benzox adi azole (DBD-PZ). Compound I was extracted from human plasma and urine, and derivatized by reaction with DBD-PZ in the presence of Mukaiyama reagent A, an equimolar solution of 2,2'-dipyridyl disulfide (DPDS) and triphenylphosphine (TPP) in acetonitrile. The reaction mixture was cleaned up by liquid liquid extraction following the derivatization. The conjugate was analyzed by ion-pair-HPLC with fluorometric detection. The quantitation limits for I were 0.5 ng/ml in plasma and 5 ng/ml in urine. Using this method, plasma concentration and urinary excretion of I were studied after oral administration of I to human volunteers.
Related Compounds
Related Articles:
1992-01-01
[Biomed. Chromatogr. 6 , 143, (1992)]
1999-05-01
[Anal. Biochem. 269(2) , 379-85, (1999)]
2005-12-01
[Biomed. Chromatogr. 19(10) , 788-95, (2005)]
1999-10-01
[Biomed. Chromatogr. 13(6) , 418-24, (1999)]
2006-10-01
[Biomed. Chromatogr. 20(10) , 1049-55, (2006)]